We know that people with type 2 diabetes have a higher risk for CRC, so if medications that manage diabetes can also help reduce colorectal cancer risk, or improve treatment outcomes, thats a big deal
Individual response depends on gastrointestinal tolerance, genetic factors, and lifestyle adherence
You may need support from a nutritionist or dietitian to make radical changes to your diet that you've been avoiding
Some people will notice immediate changes in appetite and begin to lose weight more quickly than others
This marks the first time a regulatory authority has formally acknowledged the link, following multiple studies suggesting an increased risk of NAION among type-2 diabetes patients taking semaglutide
GLP-1 medications like semaglutide and tirzepatide can help by regulating appetite and glucose, and research shows women in menopause respond comparably to younger patients